Articles related to Cardiology, Interventional

SGLT-2 inhibitors have emerged as a cornerstone in managing HFrEF and CKD, demonstrating substantial reductions in cardiovascular and renal adverse outcomes. This class of medications is reshaping the therapeutic approach in patients with these comorbid conditions, providing a dual benefit that was once considered challenging to achieve.

In this detailed case study, physicians will gain insights into the layered complexity of managing post-infarction complications, emphasizing the critical interplay between timely surgical intervention and vigilant post-operative monitoring in preserving patient outcomes.

In elderly patients, the heightened sensitivity to medications necessitates a tailored approach to prescribing, focusing on minimizing risks of confusion, hypotension, and falls. Consideration of safer alternatives and non-pharmacologic interventions is essential in promoting their well-being.

The multifaceted approach to obesity management is discussed in Oprah Winfrey’s latest TV special, where GLP-1 medications and the call for empathy in patient care take center stage, offering new perspectives on treatment and patient engagement.

Experience an in-depth exploration of heart failure management in Mont-Tremblant, Canada, where you’ll delve into the latest diagnostic and therapeutic advancements, gaining insights that are crucial for enhancing patient outcomes in your practice.

With stress tests potentially costing the US healthcare system up to $500 million annually and leading to unwarranted procedures, it’s time to reassess their routine use in asymptomatic patients and consider more accurate diagnostic alternatives.